Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pseudomyxoma Peritonei × molgramostim × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1 Malignant Ascites 1 Leukemia, Myeloid, Acute 1

Interventions

Mitomycin 3 Hyperthermic Intraperitoneal Chemotherapy 2 Capecitabine 2 tislelizumab 1 molgramostim 1 irinotecan sucrosofate 1 cryoprecipitate coagulum 1 Tacrolimus 1 Surveys and Questionnaires 1 Specimen Handling 1 Sirolimus 1 Radiosurgery 1 Psychiatric Rehabilitation 1 Pharmacogenomic Testing 1 Oxaliplatin 1 Nivolumab 1 Methods 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Lansoprazole 1 Ipilimumab 1 Gemcitabine 1 Fluorouracil 1 Floxuridine 1 Early Intervention, Educational 1 Cytoreduction Surgical Procedures 1 Clarithromycin 1 Carboplatin 1 CTLA-4 Antigen 1 Bromelains 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07341360 2026-01-14

Pseudovax

Oslo University Hospital

Phase EARLY_PHASE1 Recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡